PURPOSE: To determine the metabolism and tissue distribution of the dietary chemoprotective agent sulforaphane following oral administration to wild-type and Nrf2 knockout (Nrf2(-/-)) mice. METHODS: Male and female wild-type and Nrf2(-/-) mice were given sulforaphane (5 or 20 μmoles) by oral gavage; plasma, liver, kidney, small intestine, colon, lung, brain and prostate were collected at 2, 6 and 24 h (h). The five major metabolites of sulforaphane were measured in tissues by high performance liquid chromatography coupled with tandem mass spectrometry. RESULTS: Sulforaphane metabolites were detected in all tissues at 2 and 6 h post gavage, with the highest concentrations in the small intestine, prostate, kidney and lung. A dose-dependent increase in sulforaphane concentrations was observed in all tissues except prostate. At 5 μmole, Nrf2(-/-) genotype had no effect on sulforaphane metabolism. Only Nrf2(-/-) females given 20 μmoles sulforaphane for 6 h exhibited a marked increase in tissue sulforaphane metabolite concentrations. The relative abundance of each metabolite was not strikingly different between genders and genotypes. CONCLUSIONS: Sulforaphane is metabolized and reaches target tissues in wild-type and Nrf2(-/-) mice. These data provide further evidence that sulforaphane is bioavailable and may be an effective dietary chemoprevention agent for several tissue sites.
PURPOSE: To determine the metabolism and tissue distribution of the dietary chemoprotective agent sulforaphane following oral administration to wild-type and Nrf2 knockout (Nrf2(-/-)) mice. METHODS: Male and female wild-type and Nrf2(-/-) mice were given sulforaphane (5 or 20 μmoles) by oral gavage; plasma, liver, kidney, small intestine, colon, lung, brain and prostate were collected at 2, 6 and 24 h (h). The five major metabolites of sulforaphane were measured in tissues by high performance liquid chromatography coupled with tandem mass spectrometry. RESULTS:Sulforaphane metabolites were detected in all tissues at 2 and 6 h post gavage, with the highest concentrations in the small intestine, prostate, kidney and lung. A dose-dependent increase in sulforaphane concentrations was observed in all tissues except prostate. At 5 μmole, Nrf2(-/-) genotype had no effect on sulforaphane metabolism. Only Nrf2(-/-) females given 20 μmoles sulforaphane for 6 h exhibited a marked increase in tissue sulforaphane metabolite concentrations. The relative abundance of each metabolite was not strikingly different between genders and genotypes. CONCLUSIONS:Sulforaphane is metabolized and reaches target tissues in wild-type and Nrf2(-/-) mice. These data provide further evidence that sulforaphane is bioavailable and may be an effective dietary chemoprevention agent for several tissue sites.
Authors: Agnieszka Jazwa; Ana I Rojo; Nadia G Innamorato; Marlen Hesse; Javier Fernández-Ruiz; Antonio Cuadrado Journal: Antioxid Redox Signal Date: 2011-03-28 Impact factor: 8.401
Authors: Shivendra V Singh; Renaud Warin; Dong Xiao; Anna A Powolny; Silvia D Stan; Julie A Arlotti; Yan Zeng; Eun-Ryeong Hahm; Stanley W Marynowski; Ajay Bommareddy; Dhimant Desai; Shantu Amin; Robert A Parise; Jan H Beumer; William H Chambers Journal: Cancer Res Date: 2009-02-17 Impact factor: 12.701
Authors: Tin Oo Khor; Mou-Tuan Huang; Auemduan Prawan; Yue Liu; Xingpei Hao; Siwang Yu; William Ka Lung Cheung; Jefferson Y Chan; Bandaru S Reddy; Chung S Yang; Ah-Ng Kong Journal: Cancer Prev Res (Phila) Date: 2008-03-31
Authors: Astrid Steinbrecher; Katharina Nimptsch; Anika Hüsing; Sabine Rohrmann; Jakob Linseisen Journal: Int J Cancer Date: 2009-11-01 Impact factor: 7.396
Authors: William O Osburn; Baktiar Karim; Patrick M Dolan; Guosheng Liu; Masayuki Yamamoto; David L Huso; Thomas W Kensler Journal: Int J Cancer Date: 2007-11-01 Impact factor: 7.396
Authors: Lauren L Atwell; Laura M Beaver; Jackilen Shannon; David E Williams; Roderick H Dashwood; Emily Ho Journal: Curr Pharmacol Rep Date: 2015-04-01
Authors: Lyndsey E Shorey; Erin P Madeen; Lauren L Atwell; Emily Ho; Christiane V Löhr; Clifford B Pereira; Roderick H Dashwood; David E Williams Journal: Toxicol Appl Pharmacol Date: 2013-04-06 Impact factor: 4.219
Authors: Lauren L Atwell; Zhenzhen Zhang; Motomi Mori; Paige Farris; John T Vetto; Arpana M Naik; Karen Y Oh; Philippe Thuillier; Emily Ho; Jackilen Shannon Journal: Cancer Prev Res (Phila) Date: 2015-10-28
Authors: Besma Abbaoui; Kenneth M Riedl; Robin A Ralston; Jennifer M Thomas-Ahner; Steven J Schwartz; Steven K Clinton; Amir Mortazavi Journal: Mol Nutr Food Res Date: 2012-10-05 Impact factor: 5.914